Connect with us
How Stem Cell Treatment Can Help Multiple Sclerosis Patients
STEP 1
Uncomplicate The Condition
Multiple Sclerosis (MS) is an autoimmune disease in which the body’s immune system attacks and destroys ‘myelin’, the protective covering of nerve fibers in the brain and spinal cord. It is a progressive and often disabling condition with symptoms such as muscle weakness, poor coordination, sensation issues and vision problems. Relapse-remitting MS (RRMS), Secondary progressive MS (SPMS) and Primary progressive MS (PPMS) are the commonly occurring types of Multiple Sclerosis.
STEP 2
Available Treatment Options
As a conventional approach to treating Multiple Sclerosis, steroids and immunosuppressants are used along with rehabilitative therapies like physiotherapy and occupational therapy. However, these offer only symptomatic relief and do not address the underlying cause ie. the demyelination process. Regenerative therapy using stem cells is increasingly becoming the preferred treatment modality for Multiple Sclerosis patients.
STEP 3
IMPROVE THE QUALITY OF LIFE
Stem cells have the potential to repair and regenerate the damaged and non-functional nerve cells in MS patients. Stem cell treatment can slow down the disease progression and has shown benefits like improvements in muscle strength, vision and coordination in patients with Multiple Sclerosis.
What to Expect
- Improved Motor Power
- Reduced Tingling and Numbness
- Better Coordination
- Improved Bladder & Bowel Function
- Improved Cognition
- Improved Vision
- Improved EDSS Scores
Nutech MediWorld's Approach to Multiple Sclerosis Treatment
At Nutech MediWorld, we assess the patients’ clinical condition using conventional tools like the EDSS, MRI, etc. to check their eligibility for stem cell treatment for Multiple Sclerosis.
We also conduct an additional round of thorough assessment using our proprietary NFS (Nutech Functional System) protocols wherein condition-based parameters are used for a finer assessment of the patient’s condition (and progress).
After evaluating the patient’s condition, a customized treatment protocol is created for the patient. This protocol is based on our proprietary stem cell platform, ReoStem®.
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response.
At the end of the treatment period, a complete assessment is done to track progress from when the patient came in to where he/she has reached. If required, a follow-up treatment protocol is recommended.
At Nutech MediWorld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Multiple Sclerosis patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient.
At Nutech Mediworld, we follow an evidence-based, non-invasive, multi-disciplinary approach using Stem Cell Treatment & supporting therapies to improve the condition and overall quality of life for Multiple Sclerosis patients. Each treatment protocol comprises of the use of our patented technology, customized to suit the condition of the individual patient
At Nutech Mediworld, we assess the patients’ clinical condition using conventional tools like the EDSS, MRI etc. to check their eligibility for stem cell treatment for Multiple Sclerosis
We also conduct an additional round of thorough assessment using our proprietary NFS (Nutech Functional System) protocols wherein condition-based parameters are used for a finer assessment of the patient’s condition (and progress)
After evaluating the patient’s condition, a customized treatment protocol is created for the patient. This protocol is based on our proprietary stem cell platform, ReoStem
The patient’s progress is monitored on a weekly basis to further optimize treatment protocols depending on the patient’s response
At the end of the treatment period, a complete assessment is done to track progress from when the patient came into where he/she has reached. If required, a follow-up treatment protocol is recommended
Nutech MediWorld's Proprietary Technology For Multiple Sclerosis Treatment
Patent Protected ReoStem® Technology
We use SCT-N® and SCT-NX® products, based on ReoStem®, a proprietary stem cell platform, which comprises of a unique, replicable, clinical-stage technology for the generation and clinical application of allogenic stem cells.
Universal Applicability
Nutech MediWorld’s regenerative medicine products are universally applicable: they do not require tissue-matching or the co-administration of immunosuppressive drugs.
Highest Standards Of Safety
There is no evidence of teratoma generation or tumorigenesis associated with SCT-N® or SCT-NX® use in over 17 years of clinical practice across thousands of patients.
Cell Scalability & Expansion
The unique cell culture methodology allows scalability of cell expansion and production.